The Global Mesenchymal Stem Cells (MSCs) Market had a size of USD 3.01 billion in 2022 and is projected to reach USD 86.28 billion by 2032, with a compound annual growth rate (CAGR) of 12% during the forecast period. The growth in market revenue is driven by various factors, including the increasing incidence of chronic diseases, growing demand for regenerative medicine, and a better...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian